Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziying Lin

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Scientific Reports|December 10, 2020
Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structureZiying Lin, Lixia Huang, ShaoLi Li, et al.
Combinatorial Chemistry & High Throughput Screening|September 6, 2022
Exploring Anti-osteoporosis Medicinal Herbs using Cheminformatics and Deep Learning ApproachesZiying Lin, Shengjun Wang, Zhihong Liu, et al.
RSC Advances|May 6, 2022
Self-organized nanocrystal rings formed by microemulsion for selective recognition of proteins and immunoassaysJing Liang, Lei Yu, Ziying Lin, et al.
Clinical Laboratory|December 9, 2015
Adenovirus-Mediated E2F-1 Gene Transfer Augments Gemcitabine-Induced Apoptosis in Human Colon Cancer CellsZiying Lin, Nina Ren, Yun Jiang, et al.
Frontiers in Pharmacology|October 8, 2025
Case Report: Treatment response of SQSTM1-ALK fusion lung adenocarcinoma to multiple ALK inhibitorsJincui Gu, Jing Zhang, Shaoli Li, et al.
Molecular and Cellular Biochemistry|January 4, 2014
Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemiaXishan Zhu, Ziying Lin, Jing Du, et al.
BMC Cancer|April 20, 2021
PTEN loss correlates with T cell exclusion across human cancersZiying Lin, Lixia Huang, Shao Li Li, et al.
Medicine|May 19, 2026
The differences in CT findings between schwannoma in mediastinum and retroperitoneumZhen Yan, Ziying Lin, Siqi Feng, et al.
Frontiers in Oncology|December 11, 2025
Redox phenotype confers T cell-exclusion microenvironment and resistance to immunotherapy by suppressing <i>STING</i>/<i>MDA5</i> expression and interferon signaling in lung cancers harboring <i>KEAP1</i>/<i>STK11</i> mutationsAshish Shrestha, Yangchan Li, Lixia Huang, et al.
Oncotarget|March 2, 2016
The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literaturesZiying Lin, Yutong Xu, Yaxiong Zhang, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Scientific Reports|December 10, 2020
Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structureZiying Lin, Lixia Huang, ShaoLi Li, et al.
Combinatorial Chemistry & High Throughput Screening|September 6, 2022
Exploring Anti-osteoporosis Medicinal Herbs using Cheminformatics and Deep Learning ApproachesZiying Lin, Shengjun Wang, Zhihong Liu, et al.
RSC Advances|May 6, 2022
Self-organized nanocrystal rings formed by microemulsion for selective recognition of proteins and immunoassaysJing Liang, Lei Yu, Ziying Lin, et al.
Clinical Laboratory|December 9, 2015
Adenovirus-Mediated E2F-1 Gene Transfer Augments Gemcitabine-Induced Apoptosis in Human Colon Cancer CellsZiying Lin, Nina Ren, Yun Jiang, et al.
Frontiers in Pharmacology|October 8, 2025
Case Report: Treatment response of SQSTM1-ALK fusion lung adenocarcinoma to multiple ALK inhibitorsJincui Gu, Jing Zhang, Shaoli Li, et al.
Molecular and Cellular Biochemistry|January 4, 2014
Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemiaXishan Zhu, Ziying Lin, Jing Du, et al.
BMC Cancer|April 20, 2021
PTEN loss correlates with T cell exclusion across human cancersZiying Lin, Lixia Huang, Shao Li Li, et al.
Medicine|May 19, 2026
The differences in CT findings between schwannoma in mediastinum and retroperitoneumZhen Yan, Ziying Lin, Siqi Feng, et al.
Frontiers in Oncology|December 11, 2025
Redox phenotype confers T cell-exclusion microenvironment and resistance to immunotherapy by suppressing <i>STING</i>/<i>MDA5</i> expression and interferon signaling in lung cancers harboring <i>KEAP1</i>/<i>STK11</i> mutationsAshish Shrestha, Yangchan Li, Lixia Huang, et al.
Oncotarget|March 2, 2016
The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literaturesZiying Lin, Yutong Xu, Yaxiong Zhang, et al.
Pageof 9